, Tracking Stock Market Picks
Enter Symbol:
Rating: STJ
Hold $77
up 27.00 %

St. Jude Medical, Inc. (NYSE: STJ) downgraded to Hold with price target $77 by Deutsche Bank

Thursday,  Jul 23, 2015  1:25 PM ET by Dave Ficere

Deutsche Bank downgraded St. Jude Medical, Inc. (NYSE: STJ) to Hold with price target $77. Previously Deutsche Bank rated Buy with price target $64 St. Jude
Medical, Inc. (NYSE: STJ) on 12/16/2013, when the stock price was $59.24. Since then, St. Jude Medical, Inc.'s stock price has gained 27% as of 07/23/2015's recent price of $75.52.
If you would have followed the previous Deutsche Bank's recommendation on STJ, you would have gained 27% of your investment in 584 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy